trending Market Intelligence /marketintelligence/en/news-insights/trending/x12excv9azr6osdau_xp4g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Ampio Pharmaceuticals chief scientific officer to retire

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Ampio Pharmaceuticals chief scientific officer to retire

Ampio Pharmaceuticals Inc. said David Bar-Or will retire as chief scientific officer, effective Sept. 30.

Bar-Or will remain on the Englewood, Colo.-based biopharmaceutical company's board.

He said he plans to do some projects at the Trauma Research Center where he serves as research director for eight medical institutions.